Detection of oncofetal H19 RNA in rheumatoid arthritis synovial tissue

American Journal of Pathology

Volumn 163, Issue 3, 2003, Pages 901-911

  Stuhlmüller, Bruno ^a   Kunisch, Elke ^b   Franz, Juliane ^a   Martinez Gamboa, Lorena ^a   Hernandez, Maria M ^a   Pruss, Axel ^a   Ulbrich, Norbert ^c   Erdmann, Volker A ^c   Burmester, Gerd R ^a   Kinnet, Raimund W ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; ONCOFETAL ANTIGEN; ONCOFETAL H19 RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL AGGREGATION; CELL CULTURE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; LYMPHOID CELL; MACROPHAGE; MALE; OSTEOARTHRITIS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REACTIVE ARTHRITIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; STARVATION; STROMA; SYNOVIUM;

EID: 0041924829     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63450-5     Document Type: Article

References (61)

1. Gay S: Rheumatoid arthritis. Curr Opin Rheumatol 2001, 13:191-192
2. Kinne RW, Palombo-Kinne E, Emmrich F: Activation of synovial fibroblasts in rheumatoid arthritis. Ann Rheum Dis 1995, 54:501-504
3. Yamanishi Y, Firestein GS: Pathogenesis of rheumatoid arthritis: the role of synoviocytes. Rheum Dis Clin North Am 2001, 27:355-371
4. Aupperle KR, Boyle DL, Hendrix M, Seftor EA, Zvaifler NJ, Barbosa M, Firestein GS: Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene. Am J Pathol 1998, 152:1091-1098
5. Tak PP, Zvaifler NJ, Green DR, Firestein GS: Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today 2000, 21:78-82
6. Dunger S, Neumann S, Zell R, Birch-Hischfeld E, Stelzner A, Paschke R, Kinne RW, Sickinger S: Mutation detection in mosaic situations: RNA mismatch assay and denaturing gradient gel electrophoresis are more sensitive than conventional cycle sequencing. Anal Biochem 2001, 294:89-93
7. Schett G, Tohidast-Akrad M, Steiner G, Smolen J: The stressed synovium. Arthritis Res 2001, 3:80-86
8. Burmester GR, Stuhlmuller B, Keyszer G, Kinne RW: Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis? Arthritis Rheum 1997, 40:5-18
9. Erdmann VA, Szymanski M, Hochberg A, Groot N, Barciszewski J: Non-coding, mRNA-like RNAs database Y2K. Nucleic Acids Res 2000, 28:197-200
10. Erdmann VA, Barciszewska MZ, Hochberg A, de Groot N, Barciszewski J: Regulatory RNAs. Cell Mol Life Sci 2001, 58:960-977
11. Ariel I, de Groot N, Hochberg A: Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection. Am J Med Genet 2000, 91:46-50
12. Hurst LD, Smith NG: Molecular evolutionary evidence that H19 mRNA is functional. Trends Genet 1999, 15:134-135
13. Juan V, Crain C, Wilson C: Evidence for evolutionarily conserved secondary structure in the H19 tumor suppressor RNA. Nucl Acids Res 2000, 28:1221-1227
14. Goshen R, Rachmilewitz J, Schneider T, de Groot N, Ariel I, Palti Z, Hochberg AA: The expression of the H-19 and IGF-2 genes during human embryogenesis and placental development. Mol Reprod Dev 1993, 34:374-379
15. Lustig O, Ariel I, Ilan J, Lev-Lehman E, de Groot N, Hochberg A: Expression of the imprinted gene H19 in the human fetus. Mol Reprod Dev 1994, 38:239-246
16. Ariel I, Sughayer M, Fellig Y, Pizov G, Ayesh S, Podeh D, Libdeh BA, Levy C, Birman T, Tykocinski ML, de Groot N, Hochberg A: The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol 2000, 53:320-323
17. Ariel I, Ayesh S, Perlman EJ, Pizov G, Tanos V, Schneider T, Erdmann VA, Podeh D, Komitowski D, Quasem AS, de Groot N, Hochberg A: The product of the imprinted H19 gene is an oncofetal RNA. Mol Pathol 1997, 50:34-44
18. Biran H, Ariel I, de Groot N, Shani A, Hochberg A: Human imprinted genes as oncodevelopmental markers. Tumour Biol 1994, 15:123-134
19. Bertherat J, Logie A, Gicquel C, Mourrieras F, Luton JP, Le Bouc Y: Alterations of the 11p15 imprinted region and the IGFs system in a case of recurrent non-islet-cell tumour hypoglycaemia (NICTH). Clin Endocrinol 2000, 53:213-220
20. Casola S, Pedone PV, Cavazzana AO, Basso G, Luksch R, d'Amore ES, Carli M, Bruni CB, Riccio A: Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma. Oncogene 1997, 14: 1503-1510
21. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, et al: Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet 1994, 7:440-447
22. Liu J, Kahri Al, Heikkila P, Ilvesmaki V, Voutilainen R: H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. J Clin Endocrinol Metab 1995, 80:492-496
23. Yballe CM, Vu TH, Hoffman AR: Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor. J Clin Endocrinol Metab 1996, 81:1607-1612
24. Adriaenssens E, Lottin S, Dugimont T, Fauquette W, Coll J, Dupouy JP, Boilly B, Curgy JJ: Steroid hormones modulate H19 gene expression in both mammary gland and uterus. Oncogene 1999, 18:4460-4473
25. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B: Tumour-suppressor activity of H19 RNA. Nature 1993, 365:764-767
26. Ayesh S, Matouk I, Schneider T, Ohana P, Laster M, Al-Sharef W, De-Groot N, Hochberg A: Possible physiological role of H19 RNA. Mol Carcinog 2002, 35:63-74
27. Lottin S, Adriaenssens E, Dupressoir T, Berteaux N, Montpellier C, Coll J, Dugimont T, Curgy JJ: Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells. Carcinogenesis 2002, 23:1885-1895
28. Adriaenssens E, Lemoine J, El Yazidi-Belkoura I, Hondermarck H: Growth signaling in breast cancer cells: outcomes and promises of proteomics. Biochem Pharmacol 2002, 64:797-803
29. Hayashida T, Eversole-Cire P, Jones PA, Sasaki H: Imprinted genes are up-regulated by growth arrest in embryonic fibroblasts. J Biochem 1997, 122:901-903
30. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger Jr TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324
31. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley III S, Mankin H, McShane DJ, Medsger Jr T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049
32. Zimmermann T, Kunisch E, Pfeiffer R, Hirth A, Stahl H-D, Sack U, Laube A, Liesaus E, Roth A, Palambo-Kinne E, Emmrich F, Kinne RW: Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture-primary culture cells markedly differ from fourth-passage cells. Arthritis Res 2001, 3:72-76
33. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM: Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998, 273: 18623-18632
34. Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, Pirola L, Vanhaesebroeck B, Waterfield MD, Panayotou G: Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 1996, 16: 1722-1733
35. Chirgwin JM, Pryzbyla AE, MacDonald J, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 1979, 18:5294-5299
36. Kriegsmann J, Keyszer G, Geiler T, Gay RE, Gay S: A new double labeling technique for combined in situ hybridization and immunohistochemical analysis. Lab Invest 1994, 71:911-917
37. Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Müller-Ladner U, Gay RE, Gay S: Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum 2000, 43:599-607
38. Goshen R, Rachmilewitz J, Schneider T, de-Groot N, Ariel I, Palti Z, Hochberg AA: The expression of the H-19 and IGF-2 genes during human embryogenesis and placental development. Mol Reprod Dev 1993, 34:374-379
39. Sen M, Lauterbach K, El-Gabalawy H, Firestein GS, Corr M, Carson DA: Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc Natl Acad Sci USA 2000, 97:2791-2796
40. De Bari C, Dell'Accio F, Tylzanowski P, Luyten FP: Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001, 44:1928-1942
41. Han DK, Khaing ZZ, Pollock RA, Haudenschild CC, Liau G: H19, a marker of developmental transition, is reexpressed in human atherosclerotic plaques and is regulated by the insulin family of growth factors in cultured rabbit smooth muscle cells. J Clin Invest 1996, 97:1276-1285
42. Shoenfeld Y, Sherer Y, Harats D: Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol 2001, 22: 293-295
43. Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S: Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res 2000, 2:59-64
44. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvalfler NJ: Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol 1996, 149:2143-2151
45. Firestein GS, Echeverri F, Yeo M, Zwaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA 1997, 94:10985-10900
46. Han Z, Boyle DL, Shi Y, Green DR, Firestein GS: Dominant-negative p53 mutations in rheumatoid arthritis. Arthritis Rheum 1999, 42:1088-1092
47. Yamanashi Y, Boyle DL, Pinkosi MJ, Mahboubi A, Lin T, Han Z, Zvaifler NJ, Green DR, Firestein GS: Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol 2002, 160:123-130
48. Dugimont T, Montpellier C, Adriaenssens E, Lottin S, Dumont L, Iotsova V, Lagrou C, Stehelin D, Coll J, Curgy JJ: The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53. Oncogene 1998, 16:2395-2401
49. Doyle LA, Yang W, Rishi AK, Gao Y, Ross DD: H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein. Cancer Res 1996, 56:2904-2907
50. Kinne RW, Bräuer R, Stuhlmüller B, Palombo-Kinne E, Burmester GR: Macrophages in rheumatoid arthritis. Arthritis Res 2000, 2:189-202
51. Kinne RW, Liehr T, Beensen V, Kunisch E, Zimmermann T, Holland H, Pfeiffer R, Stahl H-D, Lungershausen W, Hein G, Roth A, Emmrich F, Claussen U, Froster UG: Mosaic chromosomal aberrations in synovial fibroblasts of patients with rheumatoid arthritis, osteoarthritis, and other inflammatory joint diseases. Arthritis Res 2001, 3:319-330
52. Adriaenssens E, Lottin S, Berteaux N, Hornez L, Fauquette W, Fafeur V, Peyrat JP, LeBourhis X, Hondermarck H, Coll J, Dugimont T, Curgy JJ: Cross-talk between mesenchyme and epithelium increases H19 gene expression during scattering and morphogenesis of epithelial cells. Exp Cell Res 2002, 275:215-229
53. Certa U, Seiler M, Padovan E, Spagnoli GC: Interferon-α sensitivity in melanoma cells: detection of potential response marker genes. Recent Results Cancer Res 2002, 160:85-91
54. Veilleux C, Bernardino J, Gibaud A, Niveleau A, Malfoy B, Dutrillaux B, Bourgeois CA: Changes in methylation of tumor cells: a new in situ quantitative approach on interphase nuclei and chromosomes. Bull Cancer 1995, 82:939-945
55. Nyce J: Drug-induced DNA hypermethylation and drug resistance in human tumors. Cancer Res 1989, 49:5829-5836
56. Stephenson J, Akdag R, Ozbek N, Mufti GJ: Methylation status within exon 3 of the c-myb gene as a prognostic marker in myeloma and leukemia. Leuk Res 1993, 17:291-293
57. Evans JL, Boyle WJ, Ting JP: Molecular basis of elevated c-myb expression in the abnormal L3T4-, Lyt-2- T lymphocytes of autoimmune mice. J Immunol 1987, 139:3497-3505
58. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M: Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1990, 33: 1665-1673
59. Corvetta A, Della Bitta R, Luchetti MM, Pomponio G: 5-Methylcytosine content of DNA in blood, synovial mononuclear cells and synovial tissue from patients affected by autoimmune rheumatic diseases. J Chromatogr 1991, 566:481-491
60. Kim YI, Logan JW, Mason JB, Roubenoff R: DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. J Lab Clin Med 1996, 128:165-172
61. Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME, Gay RE, Gay S: Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum 2000, 43:2634-2647